New combo treatment may offer longer hip pain relief without surgery
NCT ID NCT07360093
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for chronic hip pain caused by osteoarthritis: a nerve block alone versus a nerve block plus pulsed radiofrequency. About 84 adults with hip pain lasting at least 3 months will be enrolled. The goal is to see if adding radiofrequency provides better and longer pain relief and improves hip function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Pericapsular nerve group (PENG) block and pulsed radiofrequency (PRF) procedure
- What this could lead to
- If it works, this could offer a longer-lasting, non-surgical option for managing chronic hip pain from osteoarthritis.
- What could go wrong
- This is a small, early-stage study (84 people) comparing two procedures, so results may not apply widely. The nerve block only helps those who respond well, and adding PRF may not provide extra benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
18-80 years old with chronical hip pain
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Presence of chronic hip pain lasting at least 3 months * Baseline Visual Analog Scale (VAS) score ≥ 4 * Clinical and/or radiological diagnosis of hip osteoarthritis * Inadequate response to conservative treatments Exclusion Criteria: * Local or systemic infection at the intervention site * Coagulopathy or inability to discontinue anticoagulant therapy * Hip pain related to malignancy * History of previous hip arthroplasty * Severe neurological deficit * Pregnancy or breastfeeding
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteoarthritis (OA) of the hip are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
RECRUITINGAnkara, 06680, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wrist trackers vs. feelings: the Sleep-Pain puzzle in arthritis
- Could a short steroid course ease sudden joint pain?
- Virtual program aims to keep joint replacement patients moving while they wait
- Could a three-day pill course after joint replacement speed up recovery?
- Hip implant under the microscope: how does the tipmed system hold up in daily use?
- Could a keto diet ease arthritis pain and boost brain function?